Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Objective Response”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Not applicableLooking for participantsNCT05036564
What this trial is testing

Diagnosis; Objective RespOnse; THErApy

Who this might be right for
Primary CNS Lymphoma
IRCCS San Raffaele 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02407405
What this trial is testing

MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1 (NF1)Plexiform Neurofibromas (PN)
National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT05336357
What this trial is testing

Non-invasive Goal-directed thErapy oN cIrcUlatory Shock

Who this might be right for
Hemodynamics Instability
University of Sao Paulo 380
Not applicableUnknownNCT01724463
What this trial is testing

Electronic Application of a Severe Sepsis Screening Tool and Management Bundle

Who this might be right for
Systemic Inflammatory Response Syndrome (SIRS)SepsisSevere Sepsis+1 more
University of Tennessee 30,000
Testing effectiveness (Phase 2)Looking for participantsNCT07150247
What this trial is testing

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Who this might be right for
BRAF V600 Colorectal Cancer
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06848842
What this trial is testing

Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Early research (Phase 1)Study completedNCT00481728
What this trial is testing

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Who this might be right for
Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28
Not applicableNot Yet RecruitingNCT07371299
What this trial is testing

Correlations Between Subjective and Objective Responses to Cochlear Implant Stimulation

Who this might be right for
Severe to Profound Sensorineural Hearing Loss
Assistance Publique - Hôpitaux de Paris 60
Post-approval studies (Phase 4)Study completedNCT05223244
What this trial is testing

Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC

Who this might be right for
Interstitial CystitisPainful Bladder Syndrome
Endeavor Health 83
Testing effectiveness (Phase 2)Looking for participantsNCT04512534
What this trial is testing

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Fudan University 51
Not applicableWithdrawnNCT02266654
What this trial is testing

Early Goal Directed Therapy in Sepsis by Emergency Medical Services

Who this might be right for
Sepsis
Massachusetts General Hospital
Testing effectiveness (Phase 2)UnknownNCT05234905
What this trial is testing

H101 Combined With Camrelizumab for Recurrent Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsOncolytic VirotherapyCamrelizumab
Zhejiang Cancer Hospital 55
Very early researchActive Not RecruitingNCT06572956
What this trial is testing

Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors

Who this might be right for
Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc
The Second Hospital of Shandong University 10
Not applicableStudy completedNCT02693262
What this trial is testing

Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds

Who this might be right for
Heart FailureICDChronotropic Incompetence
University of California, San Diego 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07145931
What this trial is testing

Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaSkull Base--CancerNeoadjuvant Chemoimmunotherapy+1 more
Sun Yat-sen University 24
Testing effectiveness (Phase 2)UnknownNCT01763450
What this trial is testing

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
Liaoning Cancer Hospital & Institute 100
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Not applicableEnded earlyNCT01933451
What this trial is testing

Outcome Study of Restrictive vs. Liberal Intraoperative Fluid Management Guided by PPV in Esophagectomy

Who this might be right for
Other Complications of Esophagostomy
National Taiwan University Hospital 7
Testing effectiveness (Phase 2)UnknownNCT04670978
What this trial is testing

Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Who this might be right for
Objective Response Rate
Shandong University 96
Post-approval studies (Phase 4)Study completedNCT00979706
What this trial is testing

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

Who this might be right for
HIV
Juan A. Arnaiz 22
Load More Results